Ultragenyx Pharmaceutical Inc.

By person

24 insiders · 254 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

KAKKIS EMIL D

President & CEO

$612.07K (3)

$36.98M (26)

−$36.37M

7,444,206

$101.02M

+1.5%

Sharp Shalini

EVP, Finance

—

$11.97M (25) scheduled

−$11.97M

97,812

$1.33M

+106.5%

Parschauer Karah Herdman

EVP and Chief Legal Officer

—

$10.02M (35) scheduled

−$10.02M

92,562

$1.26M

+498.4%

Bedrosian Camille L

EVP and Chief Medical Officer

—

$6.04M (12) scheduled

−$6.04M

46,720

$633.99K

—

Aliski William

Director

—

$5.45M (11)

−$5.45M

185,655

$2.52M

−9.4%

Kassberg Thomas Richard

CBO & EVP

—

$3.85M (11)

−$3.85M

264,730

$3.59M

+209.2%

SIEGALL CLAY B

Director

—

$2.97M (3) scheduled

−$2.97M

2,550

$34.60K

+36.0%

Pinion John Richard

See Remarks

—

$2.84M (11)

−$2.84M

133,142

$1.81M

+1,643%

Huizenga Theodore Alan

SVP, Chief Accounting Officer

—

$2.80M (37) scheduled

−$2.80M

67,863

$920.90K

+288.1%

Harris Erik

EVP & Chief Commercial Officer

—

$2.66M (19)

−$2.66M

118,410

$1.61M

+902.3%

Fust Matthew K

Director

—

$2.32M (8) scheduled

−$2.32M

33,696

$457.25K

+155.4%

Horn Howard

Chief Financial Officer

—

$1.80M (14) scheduled

−$1.80M

96,295

$1.31M

—

Huang Dennis Karl

See Remarks

—

$914.53K (6)

−$914.53K

147,845

$2.01M

+1,181%

Dier Mardi

CFO & Executive Vice President

—

$813.79K (6)

−$813.79K

66,695

$905.05K

—

Crombez Eric

EVP and Chief Medical Officer

—

$662.61K (8)

−$662.61K

111,189

$1.51M

+299.3%

Sanders Corazon (Corsee) D.

Director

—

$339.40K (6) scheduled

−$339.40K

21,095

$286.26K

—

SULIMAN SHEHNAAZ

Director

—

$144.19K (1) scheduled

−$144.19K

27,951

$379.30K

—

WELCH DANIEL G

Director

—

40,441

$548.78K

+2,057%

NARACHI MICHAEL

Director

—

40,441

$548.78K

+2,057%

Dunsire Deborah

Director

—

38,566

$523.34K

—

Ray Amrit

Director

—

31,116

$422.24K

—

Dallas Jayson Donald Alexander

EVP & Chief Commercial Officer

—

23,830

$323.37K

+77.9%

Hogenhuis Wladimir

Chief Operating Officer

—

18,703

$253.80K

—

Ekman Lars

Director

—

17,745

$240.80K

+846.4%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Insider

Date

Role

Action

Price

Amount

Huizenga Theodore Alan

15 Sep 2026

SVP, Chief Accounting Officer

Sold on a plan

1,283

$13.57

$17.41K

Horn Howard

3 Aug 2026

Chief Financial Officer

Sold on a plan

4,696

$24.92

$117.02K

Parschauer Karah Herdman

3 Aug 2026

EVP and Chief Legal Officer

Sold on a plan

1,900

$24.92

$47.35K

Horn Howard

1 Jul 2026

Chief Financial Officer

Sold on a plan

4,698

$33.13

$155.64K

Parschauer Karah Herdman

15 Jun 2026

EVP and Chief Legal Officer

Sold on a plan

1,899

$24.62

$46.75K

Horn Howard

1 Jun 2026

Chief Financial Officer

Sold on a plan

4,653

$23.77

$110.60K

SULIMAN SHEHNAAZ

18 May 2026

Director

Sold on a plan

5,740

$25.12

$144.19K

Horn Howard

1 May 2026

Chief Financial Officer

Sold on a plan

4,683

$24.90

$116.61K

Horn Howard

1 Apr 2026

Chief Financial Officer

Sold on a plan

4,683

$20.97

$98.20K

Horn Howard

3 Mar 2026

Chief Financial Officer

Sold on a plan

1,635

$22.40

$36.62K

Horn Howard

2 Mar 2026

Chief Financial Officer

Sold on a plan

3,119

$22.54

$70.30K

Horn Howard

2 Mar 2026

Chief Financial Officer

Sold on a plan

5,290

$22.80

$120.61K

Horn Howard

2 Feb 2026

Chief Financial Officer

Sold on a plan

3,061

$23.56

$72.12K

Horn Howard

2 Jan 2026

Chief Financial Officer

Sold on a plan

3,150

$22.84

$71.95K

Horn Howard

10 Dec 2025

Chief Financial Officer

Sold on a plan

3,081

$36.38

$112.09K

Sanders Corazon (Corsee) D.

20 Jun 2025

Director

Sold on a plan

2,405

$37.39

$89.92K

KAKKIS EMIL D

3 Mar 2025

President & CEO

Sold on a plan

73,434

$42.10

$3.09M

KAKKIS EMIL D

28 Feb 2025

President & CEO

Sold on a plan indirect

25,000

$42.48

$1.06M

KAKKIS EMIL D

30 Dec 2024

President & CEO

Sold on a plan indirect

11,727

$42.23

$495.23K

KAKKIS EMIL D

10 Dec 2024

President & CEO

Sold on a plan indirect

8,273

$50.00

$413.65K

KAKKIS EMIL D

3 Sep 2024

President & CEO

Sold on a plan indirect

20,000

$55.85

$1.12M

KAKKIS EMIL D

6 Aug 2024

President & CEO

Sold on a plan indirect

20,000

$50.17

$1.00M

Sanders Corazon (Corsee) D.

2 Jul 2024

Director

Sold on a plan

584

$40.98

$23.93K

Parschauer Karah Herdman

12 Jun 2024

EVP and Chief Legal Officer

Sold on a plan

9,806

$45.00

$441.27K

Sanders Corazon (Corsee) D.

10 Jun 2024

Director

Sold on a plan

1,737

$41.10

$71.39K

Fust Matthew K

7 Mar 2024

Director

Sold on a plan

7,500

$50.88

$381.60K

Fust Matthew K

7 Mar 2024

Director

Sold on a plan

2,145

$50.85

$109.07K

Fust Matthew K

7 Mar 2024

Director

Sold on a plan

2,550

$50.89

$129.77K

Showing 250 of 254 transactions. The figures above use every one of them.

Ultragenyx Pharmaceutical Inc.

By person

Individual transactions

What was left out